Oluseyi Adeboye Akinloye
Overview
Explore the profile of Oluseyi Adeboye Akinloye including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
180
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Onifade O, Akinloye O, Dosumu O, Shotuyo A
Food Chem Toxicol
. 2023 Oct;
182:114096.
PMID: 37858842
Hepatocellular carcinoma (HCC) is the most frequent primary malignancy of the liver. The aim of this study is to evaluate the comparative in silico and in vivo ameliorative potential of...
2.
Ore A, Adeogun A, Akinloye O
Medicines (Basel)
. 2022 Jan;
9(1).
PMID: 35049934
Tamoxifen (TMX) has proven to be effective in the prevention and treatment of breast cancer. However, long-term use of TMX is associated with hepatic steatosis, oxidative liver injury and hepatocarcinoma....
3.
Metibemu D, Akinloye O, Omotuyi I, Okoye J, Popoola M, Akamo A
Front Oncol
. 2021 Sep;
11:687190.
PMID: 34532287
Human epidermal growth factor 2 (HER2) is overexpressed in about 20% of breast cancer and is associated with a poor prognosis. We report in this study that carotenoid-enriched fractions from...
4.
Ore A, Akinloye O
Medicina (Kaunas)
. 2021 Aug;
57(8).
PMID: 34441028
Non-alcoholic fatty liver disease (NAFLD), or metabolic dysfunction-associated fatty liver disease (MAFLD), is a metabolic condition distinguished by fat deposition in the hepatocytes. It has a prevalence of about 25%...
5.
Metibemu D, Akinloye O, Akamo A, Okoye J, Ojo D, Morifi E, et al.
Toxicol Rep
. 2021 Aug;
8:489-498.
PMID: 34408968
Vascular endothelial growth factor (VEGF) and its receptor-2 (VEGFR-2) mediated tumorigenesis, metastasis, and angiogenesis are the cause of the increased levels of mortality associated with breast cancer and other forms...
6.
Metibemu D, Akinloye O, Akamo A, Okoye J, Omotuyi I
J Pharm Pharmacol
. 2021 Aug;
73(10):1377-1386.
PMID: 34343336
Objectives: Inhibition of HMG-CoA (3-hydroxy-3-methylglutaryl coenzyme A) reductase, the rate rate-determining enzyme for the biogenesis of cholesterol is known to show antineoplastic effects. Therefore, this study investigates the in-silico HMG-CoA...
7.
Ore A, Akinloye O, Adeogun A, Ugbaja R, Morifi E, Makatini M, et al.
J Food Biochem
. 2021 Jun;
46(3):e13836.
PMID: 34184286
Non-alcoholic fatty liver disease (NAFLD) is a hepatic condition with multiple pathological features and it currently has no specific treatment or approved drug. Wonderful kolanut widely consumed fresh or cooked...
8.
Ugbaja R, Fatokun T, Akinloye D, James A, Onabanjo O, Akinloye O
J Diabetes Metab Disord
. 2021 Jun;
20(1):683-696.
PMID: 34178859
Background And Aim: Diabetes is a major cause of death worldwide and currently available allopathic drugs presents adverse side effects, thus, necessitating a continuous screening for natural products. This study...
9.
Metibemu D, Akinloye O, Akamo A, Okoye J, Ojo D, Morifi E, et al.
J Food Biochem
. 2020 Oct;
44(12):e13523.
PMID: 33084091
Breast cancer is the most prevalent cancer in women. X-linked inhibitor of apoptosis protein (XIAP) that is constantly overexpressed in cancer is a promising therapeutic target in cancer treatments. The...
10.
Ore A, Ugbaja R, Adeogun A, Akinloye O
Porto Biomed J
. 2020 Aug;
5(4):e071.
PMID: 32734012
Background: Experimental diet models have proven to be vital to understanding the pathophysiology and management of nonalcoholic fatty liver disease (NAFLD). Lieber-DeCarli high-fat, liquid diet have been used to produce...